Key facts
- This page summarizes Marshall S. Stanton's Form 4 filing for ARTIVION, INC. (AORT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Aug 2025, 18:08.
Marshall S. Stanton - 27 Aug 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)
- Reporting relationship
- SVP, Clinical & MD Affair
- Issuer ticker
- AORT
- Reported as of
- 27 Aug 2025
- Net transaction value
- -$600,473
- SEC form
- 4
- Accepted by SEC
- 28 Aug 2025, 18:08:42 UTC
- Prior SEC filing
- 18 Jun 2025
- Next SEC filing
- 12 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marshall Stanton
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Marshall S. Stanton filed Form 4 for ARTIVION, INC. (AORT) on 28 Aug 2025.
Change
- Previous filing in this sequence was filed on 18 Jun 2025.
- Current net transaction value: -$600,473.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001849615
Primary reporting owner
Stanton Marshall S.
- Relationship
- SVP, Clinical & MD Affair
- Address
- 1655 ROBERTS BLVD., NW, KENNESAW
- Signature
- /s/ Marshall Stanton
- Signature date
- 28 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AORT
transaction
Common Stock
Options Exercise
- Transaction value
- $200,746
- Shares
- +18,200
- Change %
- +28%
- Price
- $11.03
- Shares after
- 82,400
- Date
- 27 Aug 2025
- Ownership
- Direct
AORT
transaction
Common Stock
Sale
- Transaction value
- $801,219
- Shares
- -18,200
- Change %
- -22%
- Price
- $44.02
- Shares after
- 64,200
- Date
- 27 Aug 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AORT
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -18,200
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 27 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,200
- Exercise price
- $11.03
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Reflects weighted average price. Range of prices were between $43.84 to $44.26. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F2
Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.